Taking a page from the Olympics, psychiatry needs to work faster, higher, and stronger--together.

The RECOVER open label trial demonstrated positive results for brilaroxazine for schizophrenia.

Although medical ethics prioritizes the patient, should the clinician get more equal consideration?

Cultivating hope in therapy enhances resilience and empowers patients to overcome mental health challenges and achieve their goals.

Championing diverse voices: check out our June theme! We want to hear about your insights, tips, and case studies.

Busy Philipps and Ann Childress, MD, explore the unique challenges women face in ADHD diagnosis, highlighting personal stories and the importance of treatment.

Discover key insights from the APA Annual Meeting, highlighting advancements in lifestyle psychiatry, ADHD treatment, and innovative suicide prevention models.

Discover essential insights for diagnosing and treating child mental health issues in the DSM-5-TR Casebook and Treatment Guide for Child Mental Health, a vital resource for clinicians.

Check out the pipeline updates from May!

"The jackrabbit is a mild herbivore grazing the desert floor, quietly abridging spring..."

Psychiatric professionals express concern over the impact of federal changes on diversity, equity, and inclusion programs in mental health care.

Recent research reveals dopamine partial agonists significantly reduce somnolence in major depressive disorder and schizophrenia compared with D2 receptor antagonists.

In this CME article, learn more about the essential role of MAOIs in treating resistant depression and anxiety.

Cariprazine shows promise as a long-term adjunctive treatment for anhedonia in major depressive disorder, according to new poster data presented at the ASCP Annual Meeting.

Neurocrine Biosciences reveals promising phase 2 results for NBI-1117568, a novel treatment for schizophrenia, showing significant symptom improvement over placebo.

How do psychiatrists feel about the current polycrises? “Overwhelmed.”

Are we ready yet to give peace a chance?

Vincenzo Di Nicola discusses the importance of pluralism in social psychiatry and the need for culturally relevant psychotherapy at the 2025 APA Annual Meeting.

Learn more about the critical link between early adversity and psychosis, and the need for targeted interventions and preventive measures.

Online dating transforms connections but often leads to loneliness and mental health issues. How can we encourage safer, more meaningful interactions?

Explore the complex role of dopamine in schizophrenia, its impact on symptoms, and potential therapeutic advancements.

Psychiatrists united in Los Angeles for a rally, advocating for mental health funding amidst growing concerns over service cuts and societal challenges.

Phillip R. Muskin, MD, discusses the complexities of prescribing antipsychotics, emphasizing patient collaboration and the importance of evaluating treatment strategies.

Early intervention in schizophrenia enhances recovery, reduces symptoms, and improves quality of life through coordinated specialty care programs across the US.

"There are a million birds in this city I hadn’t heard till now, each of them tuning their instruments, each of them singing, I am alive."